Showing 1761-1770 of 9077 results for "".
You Want to Start A New Practice: Now What?
https://practicaldermatology.com/topics/general-topics/PD0309_12-php/22866/After making the decision to start a practice, constructing a solid business plan and financial overview is critical.Inflamed Feelings: The Psychological Effects of Inflammatory Disorders
https://practicaldermatology.com/topics/psoriasis/PD0309_05-php/22859/Data suggest that children and adults suffering from chronic inflammatory skin diseases, such as eczema and psoriasis, are at higher risk for depression, anxiety, and other psychiatric illnesses.And the Wind Cries…Crazy
https://practicaldermatology.com/topics/practice-management/and-the-wind-criescrazy/23366/Psoriasis Therapeutics and Moving to Private Practice
https://practicaldermatology.com/series/the-practical-dermatology-podcast/program-name/35733/H.L. Greenberg, MD, discusses his recent Practical Dermatology article on the various benefits of different psoriasis therapeutics, and Tina Bhutani, MD, MAS, FAAD, joins Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss the transition from academia to private practice and playPractical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 1
https://practicaldermatology.com/series/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-1/32757/In the first installment of a six-part series, host Neal Bhatia, MD, FAAD, and guests Jason E. Hawkes, MD, MS, FAAD, and Laura K. Ferris, MD, PhD, FAAD, provide an overview of generalized pustular psoriasis, including the unique challenges it poses, triggers associated with it, and the importance ofDermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-3-year-clinical-data-lebrikizumab/28648/Study author Melinda Gooderham, MSc, MD, FRCPC, discusses the new three-year clinical data presented at the European Academy of Dermatology & Venereology (EADV) Congress on the efficacy and safety of lebrikizumab, which the FDA recently approved on September 13 for adults and adolescents with moSCALE 2024: Listen as Dr. Joel Cohen and Dr. Suneel Chilukuri on Microwave Therapy
https://practicaldermatology.com/error/404/Suneel Chilukuri, MD, discusses the various applications of microwave therapy, including non-melanoma skin cancer, with Joel Cohen, MD, at Music City SCALE.JAK Inhibitors in Vitiligo Treatment
https://practicaldermatology.com/series/updates-vitiligo/jak-inhibitors-vitiligo-treatment/24559/Dr. Ted Lain, a dermatologist practicing in Austin, Texas, talks with Practical Dermatology about the latest developments and the promise of Janus kinase (JAK) inhibitors for the treatment of vitiligo. Dr. Lain covers the current impact of JAK inhibitors, their mechanism of action, how he's using thWhat’s New for Treating Hyperhidrosis?
https://practicaldermatology.com/conferences/scale-2023/whats-new-for-treating-hyperhidrosis/20208/The treatment of hyperhidrosis has changed a lot over the years. Larry Green, MD, discusses some of the exciting innovations including targeted alkali thermolysis.Exosome Therapy: Explained
https://practicaldermatology.com/conferences/scale-2023/exosome-therapy-explained/20200/Jane Yoo, MD, explains exactly what exosomes are and highlights some current therapeutic uses for exosome therapy including treating hair loss and reducing redness after laser skin resurfacing.